IP Library › Granted Patent US 7,488,799
Granted Patent B2
US 7,488,799 · App. 11/621,164 · Granted Feb 10, 2009

Prostaglandin receptor protein

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,488,799
App. No.
11/621,164
Granted
Feb 10, 2009
Kind
B2
Abstract

Described herein is a novel member of the prostanoid receptor family, a guinea pig prostaglandin D2 receptor. Described are the receptor, the nucleic acid that encodes it, and various uses for both.

Claims (5)

1. A recombinant polypeptide comprising the amino acid sequence of SEQ ID NO:2.

2. The recombinant polypeptide of claim 1 further comprising a detectable label.

3. The recombinant polypeptide of claim 2 , wherein the detectable label comprises an enzyme, a radio active isotope, or a chemical which fluoresces.

4. A recombinant polypeptide comprising an amino acid sequence at least 95% identical to the sequence of SEQ ID NO:2 and which binds a prostanoid.

5. A recombinant polypeptide comprising an amino acid sequence at least 99% identical to the sequence of SEQ ID NO:2 and which binds a prostanoid.

Assignments (3)
MERGER Recorded Jan 19, 2015
From: AVENTIS PHARMACEUTICALS INC.
To: AVENTISUB LLC
Reel/Frame 034781/0334 →
CERTIFICATE OF CONVERSION Recorded Dec 9, 2014
From: AVENTISUB INC.
To: AVENTISUB LLC
Reel/Frame 034566/0976 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 5, 2009
From: PARKAR, ASHFAQ; AUGUST, PAUL; KUNTZWEILER, THERESA; ARDATI, MOHAMAD ALI; BASKARAN, NAMADEV
To: AVENTIS PHARMACEUTICALS INC.
Reel/Frame 022053/0670 →